# Benefit of High-flow Nasal Cannula on Persistent Dyspnea in Ild

> **NCT06617078** · NA · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 42 (estimated)

## Conditions studied

- ILD

## Interventions

- **PROCEDURE:** long-term oxygen therapy (LTOT)
- **PROCEDURE:** High Flow Nasal Therapy (HFNT)

## Key facts

- **NCT ID:** NCT06617078
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-15
- **Primary completion:** 2026-10-15
- **Final completion:** 2026-10-15
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2024-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06617078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06617078, "Benefit of High-flow Nasal Cannula on Persistent Dyspnea in Ild". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT06617078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*